>>> US After Hours Summary: MU +4.3%, MLKN +3.4% higher on earnings; CALT +26.9%

After Hours Summary: MU +4.3%, MLKN +3.4% higher on earnings; CALT +26.9% as FDA approves TARPEYO; BB -1.8% lower on earnings

After Hours Gainers:
Companies trading higher in after hours in reaction to earnings/guidance: MU +4.3%, MLKN +3.4%

Companies trading higher in after hours in reaction to news: CALT +26.9% (announces full FDA approval of TARPEYO), IMVT +6.4% (IMVT announces initial Phase 2 results for Batoclimab), ROIV +5.5% (IMVT announces initial Phase 2 results for Batoclimab), AZO +2% (increases share buyback auth by $2 bln), WDC +1.9% (in sympathy with MU earnings), LQDA +0.7% (appeals court affirms decision to invalidate all claims of UTHR patent), LUV +0.7% (reaches tentative labor deal with pilots), GIS +0.6% (approves restructuring in Q2 to enhance commercial strategy and organizational structure of its Pet segment), BSIG +0.5% (authorizes new $100 mln share repurchase program), FLNC +0.4% (responds to article relating to its Diablo Energy Storage contract), ACCO +0.4% (announces cost savings plan; to reduce headcount by 300), KRRO +0.3% (stock offering by selling shareholders), ANNX +0.3% (outlines registrational program for ANX007; also reports Phase 1 results for ANX1502; also prices $125 mln offering), JOBY +0.1% (completes series of air traffic simulations with NASA), LMND +0.1% (Co-CEOs Shai Wininger and Daniel Schreiber to return to previously roles), NSC +0.1% (files mixed shelf securities offering)

After Hours Losers:
Companies trading lower in after hours in reaction to earnings/guidance: BB -1.8%, PK -0.2%

Companies trading lower in after hours in reaction to news: IPHA -4% (files $200 mln ADS offering), FEAM -2.6% (files $50 mln mixed shelf securities offering), TXG -1.4% (launches its Xenium Catalyst Network), PLAY -1.2% (CFO to retire), ADT -0.8% (CFO to step down), RMD -0.1% (conducts voluntary global field action to update guides for all masks with magnets), STX -0.1% (in sympathy with MU earnings)

Axios : Warner Bros. Discovery in talks to merge with Paramount Global

Warner Bros. Discovery in talks to merge with Paramount Global

Warner Bros. Discovery CEO David Zaslav met with Paramount Global CEO Bob Bakish on Tuesday in New York City to discuss a possible merger, Axios has learned from multiple sources.
Why it matters: The combination would create a news and entertainment behemoth that would likely trigger further industry consolidation.
  • Zaslav also has spoken to Shari Redstone, who owns Paramount's parent company, about a deal.
  • WBD's market value was around $29 billion as of Wednesday, while Paramount's was just over $10 billion, so any merger would not be of equals.
Details: The meeting between Zaslav and Bakish, which sources say lasted several hours, took place at Paramount's headquarters in Times Square.
  • The duo discussed ways their companies could complement one another. For example, each company's main streaming service — Paramount+ and Max — could merge to better rival Netflix and Disney+.
  • It's unclear whether WBD would buy Paramount Global or its parent company, National Amusements Inc. (NAI), but a source familiar with the situation says that both options are on the table.
  • WBD is said to have hired bankers to explore the deal.
Between the lines: The deal could drive substantial synergies.
  • WBD could use its international distribution footprint to boost Paramount's franchises, while Paramount's children's programming assets could be essential to WBD's long-term streaming ambitions.
  • CBS News could be combined with CNN to create a global news powerhouse. CBS' crime dramas, such as "NCIS" and "Criminal Minds," could be combined with Investigation Discovery and TruTV.
  • CBS Sports' footprint could be combined with WBD's. For example, CBS and WBD's Turner Sports currently share TV rights for March Madness.
Be smart: Paramount is under enormous pressure to find a strategic partner or buyer, as it's staring down a mountain of debt.
  • The firm's stock jumped 12% earlier this month following a report from Puck that Skydance Media and RedBird Capital Partners were eyeing a potential deal to buy a majority stake in NAI.
  • NAI reached a deal with creditors to restructure some of its debt in September and previously slimmed down by selling Simon & Schuster. It's also in talks to unload BET.
Behind the scenes: One source familiar with the discussions says the strategy being considered mirrors Zaslav's blueprint for prior mergers.

  • When merging with Scripps in 2018 and then WarnerMedia in 2022, Zaslav kept his core strategic team in place while retaining new creative talent leaders from the companies he acquired.
  • Executives are confident that the deal would receive regulatory approval, despite D.C.'s active antitrust climate. Notably, Warner Bros. Discovery doesn't own a broadcast network, which would clear an easier path than would a combination with a company like NBC owner Comcast.
  • A tax provision used to merge WarnerMedia and Discovery expires next year, which would legally allow WBD to explore another deal.
  • Zaslav told investors last month that the company's cost-cutting measures and debt reduction now put it in a position "to allocate more capital toward growth opportunities."
Paramount, WBD and NAI declined to comment.
The bottom line: Talks between WBD and Paramount are still early and may not ultimately result in a deal. But given the acceleration of cord-cutting and the growing encroachment of Big Tech on media, neither company can remain on the sidelines for long

>>> Micron beats by $0.06, beats on revs; guides Q2 EPS above consensus, revs ab

Micron beats by $0.06, beats on revs; guides Q2 EPS above consensus, revs above consensus (78.69 -3.48)
  • Reports Q1 (Nov) loss of $0.95 per share, excluding non-recurring items, $0.06 better than the FactSet Consensus of ($1.01); revenues rose 15.7% year/year to $4.73 bln vs the $4.58 bln FactSet Consensus.
  • Non-GAAP gross margin 0.8% compared to (9.1%) in Q4 and 22.9% in 1Q23.
  • Co issues upside guidance for Q2, sees EPS of ($0.35)-($0.21) vs. ($0.62) FactSet Consensus; sees Q2 revs of $5.1-$5.5 bln vs. $4.97 bln FactSet Consensus.
  • "We expect our business fundamentals to improve throughout 2024, with record industry TAM projected for calendar 2025. Our industry-leading High Bandwidth Memory for data center AI applications illustrates the strength of our technology and product roadmaps, and we are well positioned to?capitalize on the immense opportunities artificial intelligence is fueling across end markets."

>>> US Close Dow -1.27% S&P -1.47% Nasdaq -1.50% Russell -1.89%

Closing Stock Market Summary
Today's trade looked a lot different in the early going compared to where things ended up. The Russell 2000 was up 0.9% at its early session high; the S&P 500 was up 0.2% at its high of the day; and the Nasdaq Composite was up 0.4% at its intraday high.

The market saw an abrupt reversal in afternoon trading that happened without a news catalyst. There was some talk that trading activity in zero-day options hastened the retreat, but in any case, the major indices were all overdue for a pullback after their huge run from late October and also likely fell prone to general profit-taking activity.

The afternoon slide left the major indices near their worst levels of the session with losses ranging from 1.3% to 1.9%. The S&P 500 closed just below the 4,700 level, which leaves the index up 14.1% from its low close on October 27 (4,117).

Just about everything came along for the retreat. The equal-weighted S&P 500 declined 1.7%, and the A-D line favored decliners by greater than 3-to-1 margin at the NYSE and a greater than 2-to-1 margin at the Nasdaq.

The only S&P 500 sector that declined less than 1.0% was communication services (-0.1%). A gain in Alphabet (GOOG 139.66, +1.56, +1.1%) related to a report from The Information that it is aiming to reorganize its advertising sales unit provided support to the sector.

The consumer staples (-2.0%) and utilities (-2.0%) sectors saw the steepest declines. The industrial sector fell 1.6%, due in part to a big loss in FedEx (FDX 246.25, -33.75, -12.1%) following its disappointing FY24 revenue guidance.

Geopolitical angst was a part of the market narrative today, which didn't move stocks that much, but contributed to buying interest in Treasuries. Bloomberg report that the U.S. and its allies are considering strikes against Houthi rebels in Yemen following their disruption of Red Sea shipping activity.

The 2-yr note yield fell ten basis points to 4.35% and the 10-yr note yield declined four basis points to 3.88%.
  • Nasdaq Composite: +41.2%
  • S&P 500: +22.4%
  • Russell 2000: +12.6%
  • S&P Midcap 400: +12.8%
  • Dow Jones industrial Average: +11.9%

Reviewing today's economic data:
  • Weekly MBA Mortgage Applications Index -1.5%; Prior 7.4%
  • Q3 Current Account Balance -$200.3 bln ( consensus -$201.0 bln); Prior was revised to -$216.8 bln from -$212.1 bln
  • December Consumer Confidence 110.7 ( consensus 104.0); Prior was revised to 101.0 from 102.0
    • The key takeaway from the report is the recognition that there was renewed optimism across all ages and household income levels with attention being paid to improved inflation trends, business conditions, and job availability.
  • November Existing Home Sales 3.82 mln (consensus 3.80 mln); Prior 3.79 mln
    • The key takeaway from the report is that sales of existing homes continue to be crimped by high mortgage rates, high selling prices, and limited inventory; however, the recent drop in mortgage rates is expected to be a driver of stronger sales activity in December. Existing home sales are counted when closed. New home sales are counted when contracts are signed.

Thursday's economic calendar features:
  • 08:30 ET: Weekly Initial Jobless Claims ( consensus 218K; Prior 220K) and Continuing Jobless Claims (Prior 1876K)
  • 08:30 ET: Q3 GDP - Third Estimate ( consensus 5.2%; Prior 5.2%) and Q3 GDP Deflator - Third Estimate (Briefing.com consensus 3.6%; Prior 3.6%)
  • 08:30 ET: December Philadelphia Fed Index ( consensus -3.0; Prior -5.9)
  • 10:00 ET: November Leading Indicators ( consensus -0.4%; Prior -0.8%)
  • 10:30 ET: EIA Natural Gas Inventories (Prior -55 bcf)

FT : H2O hit with investor lawsuit claiming €700mn losses

H2O hit with investor lawsuit claiming €700mn losses
Natixis, KPMG and CACEIS also sued in first major litigation relating to illiquid asset scandal

H2O Asset Management has been hit with a lawsuit in Paris from a group of aggrieved investors claiming that they incurred more than €700mn of losses due to its investments in illiquid assets.

The group of over 6,000 investors claims that H2O, as well as its former majority owner Natixis Investment Managers, the auditor of its funds KPMG, and the funds’ custodian CACEIS, are jointly liable for the losses investors incurred. The court case marks the first major litigation relating to the illiquid asset scandal.

Once a star of European investment that oversaw more than €30bn at its peak, H2O was plunged into crisis in 2019 after the Financial Times revealed it had substantial exposure to illiquid securities tied to the controversial financier Lars Windhorst.

France’s Autorité des Marchés Financiers levied a record €75mn fine against H2O earlier this year as punishment for “serious” rule breaches related to the illiquid investments, while banning its founder Bruno Crastes from managing funds for five years.

Collectif Porteurs H2O announced the litigation on Wednesday, which it said was “based on months of in-depth investigation” that had gathered evidence “demonstrating the responsibility of the H2O group companies concerned, but also the control failures of the trusted third parties”. 

“H2O fund managers invested €2.3bn in illiquid private debt securities, despite the fact that this type of investment was not only prohibited, but moreover completely at odds with the management strategy proposed to investors,” the investor association said, estimating that the loss to its 6,077 members stands at €717mn. 

The Collectif’s decision to include other parties in the lawsuit threatens to widen the fallout from the scandal beyond H2O itself.

Natixis, which is part of French banking co-operative BPCE, initially gave H2O its support in the wake of the FT’s exposé. However, it then announced in 2020 that it would dump its majority stake in the firm after French regulators stepped in and forced H2O to freeze a number of its funds. Natixis said it believed the claims were without merit and would “contest them vigorously”.

KPMG gave H2O’s funds clean audits prior to the FT’s exposé. However, it later flagged serious issues around the illiquid exposure, warning in 2021 that the accounts at several of its funds had become “impossible to certify” due to valuation uncertainties and rule breaches.

CACEIS, meanwhile, is a custody and asset servicing business jointly owned by European banks Crédit Agricole and Santander and was the longtime custodian of H2O’s funds. The AMF ruled in January that H2O’s illiquid bond investments were never eligible for funds open to retail investors.

H2O, KPMG and CACEIS did not immediately respond to a request for comment.

The lawsuit comes as H2O has continued to write down the value of its investments linked to Windhorst, who is battling insolvency proceedings against some of his companies in multiple jurisdictions. 

H2O valued its illiquid investments linked to Windhorst at €1.6bn when it hived them off into so-called “side pockets” three years ago and trapped investors’ funds.

H2O announced in January it had received a €250mn repayment from Windhorst’s investment firm Tennor. However, its fund disclosure later showed that a significant portion of this amount was repaid with new bonds rather than cash. H2O in September marked down the value of the remaining investments in these funds to just over €300mn.

The Collectif last week won a legal victory in the Paris court ahead of its main filings, when a judge ruled that H2O had “failed to provide complete and exhaustive disclosure” of communications between Lars Windhorst and H2O’s founders. The court imposed fines of €600,000 for past disclosure failings and €30,000 a day for any further delays in providing the communications.

The ruling noted that a court-appointed expert had found a number of specific examples of “incomplete” disclosures, such as “encrypted” messages and a reference to a letter “sent via an undisclosed Google address”.

>>> US Research Calls

Research Calls
  • Upgrades:
    • Bank First Corporation (BFC) upgraded to Outperform from Market Perform at Hovde Group; tgt raised to $100
    • Bank of Montreal (BMO) upgraded to Outperform from Sector Perform at National Bank Financial
    • Blend Labs (BLND) upgraded to Overweight from Equal Weight at Wells Fargo; tgt raised to $3.50
    • CIBC (CM) upgraded to Outperform from Sector Perform at National Bank Financial
    • Clear Channel Outdoor (CCO) upgraded to Overweight from Equal Weight at Wells Fargo; tgt raised to $2.75
    • Discover Financial Services (DFS) upgraded to Buy from Neutral at Citigroup; tgt raised to $133
    • Guidewire Software (GWRE) upgraded to Overweight from Equal Weight at Wells Fargo
    • KeyCorp (KEY) upgraded to Overweight from Equal-Weight at Stephens
    • MacroGenics (MGNX) upgraded to Buy from Neutral at Citigroup; tgt raised to $13
    • Newmark Group (NMRK) upgraded to Overweight from Neutral at Piper Sandler; tgt raised to $13
    • Paramount Global (PARA) upgraded to Equal Weight from Underweight at Wells Fargo; tgt raised to $18
    • Spirit Aerosystems (SPR) upgraded to Equal-Weight from Underweight at Morgan Stanley; tgt raised to $35
  • Downgrades:
    • argenx (ARGX) downgraded to Hold from Buy at Deutsche Bank
    • Cinemark (CNK) downgraded to Underweight from Equal Weight at Wells Fargo; tgt lowered to $13
    • Clear Secure (YOU) downgraded to Underweight from Equal Weight at Wells Fargo; tgt $20
    • Costco (COST) downgraded to Neutral from Buy at Northcoast; tgt $620
    • Coupang (CPNG) downgraded to Neutral from Buy at UBS; tgt lowered to $18.50
    • DocuSign (DOCU) downgraded to Underweight from Equal Weight at Wells Fargo
    • Everbridge (EVBG) downgraded to Underweight from Equal Weight at Wells Fargo
    • Floor & Decor (FND) downgraded to Hold from Buy at Stifel; tgt raised to $115
    • Grainger (GWW) downgraded to Hold from Buy at Jefferies; tgt $825
    • Hayward Holdings (HAYW) downgraded to Hold from Buy at Stifel; tgt raised to $13.50
    • HEICO (HEI) downgraded to Underweight from Equal-Weight at Morgan Stanley; tgt lowered to $174
    • Kaltura (KLTR) downgraded to Underweight from Equal Weight at Wells Fargo; tgt lowered to $1.50
    • Lowe's (LOW) downgraded to Hold from Buy at Stifel; tgt raised to $240
    • NexPoint Residential (NXRT) downgraded to Neutral from Buy at Janney; tgt $36
    • Opendoor Technologies (OPEN) downgraded to Neutral from Buy at BTIG Research
    • RingCentral (RNG) downgraded to Equal Weight from Overweight at Wells Fargo; tgt $36
    • Sonder (SOND) downgraded to Neutral from Buy at Citigroup; tgt $4
    • Salesforce (CRM) downgraded to Equal Weight from Overweight at Wells Fargo; tgt $280
    • Terex (TEX) downgraded to Hold from Buy at Jefferies; tgt lowered to $63
    • Timken (TKR) downgraded to Hold from Buy at Jefferies; tgt lowered to $85
    • Toronto-Dominion Bank (TD) downgraded to Sector Perform from Sector Outperform at Scotiabank
    • U.S. Bancorp (USB) downgraded to Equal-Weight from Overweight at Stephens
    • Zoom Video (ZM) downgraded to Underweight from Equal Weight at Wells Fargo; tgt $70
  • Others:
    • Alphabet (GOOG/L) resumed with an Outperform at Raymond James; tgt $150
    • Amazon (AMZN) resumed with a Strong Buy at Raymond James; tgt $185
    • Apogee Therapeutics (APGE) initiated with a Buy at BTIG Research; tgt $43
    • Asana (ASAN) resumed with a Neutral at DA Davidson; tgt $20
    • Ascendis Pharma (ASND) initiated with a Buy at Jefferies; tgt $150
    • ATS Corp (ATS) initiated with a Neutral at JP Morgan; tgt $45
    • Biogen (BIIB) resumed with an Overweight at Cantor Fitzgerald; tgt $311
    • Bitcoin Depot (BTM) initiated with a Market Perform at Northland Capital; tgt $3.50
    • Blackstone (BX) resumed with an Overweight at Piper Sandler; tgt $150
    • Blue Owl Capital (OWL) resumed with an Overweight at Piper Sandler; tgt $18
    • Celldex Therapeutics (CLDX) initiated with an Outperform at TD Cowen
    • Donegal Group (DGIC/A) initiated with a Neutral at Janney; tgt $15
    • Domino's Pizza (DPZ) initiated with a Buy at HSBC Securities; tgt $466
    • Forian (FORA) initiated with a Buy at ROTH MKM; tgt $5
    • GCM Grosvenor (GCMG) resumed with a Neutral at Piper Sandler; tgt $10
    • Kanzhun Limited (BZ) initiated with a Neutral at New Street; tgt $17
    • Monday.com (MNDY) resumed with a Neutral from Buy at DA Davidson; tgt $190
    • McDonald's (MCD) initiated with a Buy at HSBC Securities; tgt $317
    • Meta Platforms (META) resumed with a Strong Buy at Raymond James; tgt $425
    • Natural Gas Services (NGS) initiated with a Buy at Stifel; tgt $18
    • Nuvei Corporation (NVEI) initiated with an Overweight at Barclays; tgt $34
    • Pacira BioSciences (PCRX) initiated with an Outperform at Raymond James; tgt $42
    • Pinterest (PINS) resumed with an Outperform at Raymond James; tgt $45
    • Shake Shack (SHAK) initiated with a Hold at HSBC Securities; tgt $74
    • Snap (SNAP) resumed with an Outperform at Raymond James; tgt $20
    • Starbucks (SBUX) initiated with a Hold at HSBC Securities; tgt $107
    • SilverBow Resources (SBOW) initiated with a Neutral at Citigroup; tgt $34
    • Smartsheet (SMAR) resumed with a Buy at DA Davidson; tgt $65
    • Travelers (TRV) initiated with a Buy at Janney; tgt $215
    • Utz Brands (UTZ) initiated with a Buy at Mizuho; tgt $19
    • Virtus Investment Partners (VRTS) resumed with an Overweight at Piper Sandler; tgt $264
    • WW (WW) resumed with a Buy at Guggenheim; tgt $14
    • Yelp (YELP) resumed with a Buy at William O'Neil

>>> US Gapping Down

Gapping Down
In reaction to earnings/guidance:
  • SCS -10.2%, FDX -9.8%, GIS -2.6%, WGO -1.6%
Other news:
  • BLUE -41.1% (announces the pricing of its underwritten public offering of 83,333,333 shares of its common stock at a public offering price of $1.50/share)
  • ARGX -25.2% (reports topline results from address study of Efgartigimod SC in pemphigus; address study did not meet primary or secondary endpoints)
  • GH -9.3% (announces that the FDA Advisory Panel is tentatively scheduled to review the premarket approval application for the company's Shield blood test to screen for colorectal cancer on March 28, 2024)
  • UPS -3.4% (falling in response to FDX's disappointing guidance)
  • BVS -3.0% (appoints Robert Claypoole as its President and Chief Executive Officer and member of its Board of Directors, effective January 10, 2024)
  • TEF -2.7% (confirms that panish Council of Ministers has agreed to acquire up to 10% of Telefónica's share capital)
  • CRSP -1.8% (Chief Medical Officer Phuong Khanh Morrow, M.D., FACP resigned effective as of January 26, 2024)
  • LTHM -1.6% (will replace NCR Voyix (VYX) in the S&P MidCap 400
  • STLD -1.2% (SVP sold 12,113 shares at $123.06 worth ~$1.5 mln)
  • CBRE -1.0% (files mixed shelf securities offering)
  • AON -1.0% ( to acquire NFP; total consideration estimated to be $13.4 bln at the time of close)
Analyst comments:
  • HEI -6.5% (downgraded to Underweight from Equal-Weight at Morgan Stanley; tgt lowered to $174)
  • CNK -3.2% (downgraded to Underweight from Equal Weight at Wells Fargo; tgt lowered to $13)
  • OPEN -2.9% (downgraded to Neutral from Buy at BTIG Research)
  • DOCU -2.8% (downgraded to Underweight from Equal Weight at Wells Fargo)
  • ZM -2.0% (downgraded to Underweight from Equal Weight at Wells Fargo; tgt $70)
  • CPNG -1.6% (downgraded to Neutral from Buy at UBS; tgt lowered to $18.50)
  • HAYW -1.6% (downgraded to Hold from Buy at Stifel; tgt raised to $13.50)
  • LOW -1.5% (downgraded to Hold from Buy at Stifel; tgt raised to $240)
  • FND -1.5% (downgraded to Hold from Buy at Stifel; tgt raised to $115)
  • CRM -1.4% (downgraded to Equal Weight from Overweight at Wells Fargo; tgt $280)
  • EVBG -1.4% (downgraded to Underweight from Equal Weight at Wells Fargo)